Official List Removal - Burning Rock Biotech Limited

RNS Number : 5286E

Official List

18 September 2024

 

NOTICE OF REMOVAL OF LISTING FROM THE OFFICIAL LIST

18/09/2024 08:00

REMOVAL

Burning Rock Biotech Limited

The Financial Conduct Authority ("the FCA") removes the securities set out below from the Official List effective from 18/09/2024 08:00:

 

Security Description	Listing Category	ISIN
American Depository Shares (Each representing 10 class A ordinary shares of USD0.0002 each); fully paid	Certificates representing certain securities (depository receipts)	US12233L2060 ●

 

This notice has been issued by Issuer Management - 020 7066 8352.

Notes SEDOL numbers which are allocated by the London Stock Exchange as a Stock Exchange identifier may be found on their dealing notice. ●Denotes the security is being admitted to trading on the London Stock Exchange, a Recognised Investment Exchange. †Denotes the security is also being admitted to trading on Aquis Stock Exchange, a Recognised Investment Exchange. #Denotes the security is also being admitted to trading on Euronext, a Recognised Investment Exchange. ∼Denotes the security is also being admitted to trading on Cboe Europe, a Recognised Investment Exchange. ^Denotes the security is also being admitted to trading on Shanghai-London Stock Connect, a Recognised Investment Exchange. *Denotes the security is also being admitted to trading on IPSX Prime, a Recognised Investment Exchange. Notices issued by the FCA in respect of admission of securities to the Official List must be read in conjunction with notices issued by the relevant Recognised Investment Exchange in respect of admission of securities to trading on its markets.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NOTUBSKRSBUKARR